앉아 균형 평가 및 훈련 Vibrotactile 피드백 장치

Executive Industry Relevance

This protocol addresses a critical gap in preclinical and translational research by providing a portable, quantifiable system to assess and train seated balance—a functional endpoint relevant to neurological, musculoskeletal, and vestibular disorders. By integrating real-time motion tracking with closed-loop vibrotactile feedback, the device enables mechanistic de-risking of sensorimotor interventions prior to costly in vivo studies. Its adaptability supports early-stage target validation and phenotypic screening in disease-relevant models of postural control.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses related to sensorimotor integration and postural control pathways.
• Operational Value: Provides quantitative, reproducible posturographic outputs (e.g., root-mean-square tilt, centroidal frequency) to objectively measure target engagement.
• Predictive Value: Supports biological de-risking by quantifying how genetic or pharmacological manipulations affect balance performance under controlled sensory conditions.

Screening & Assay Development

• Assay Readiness: Generates standardized, real-time anteroposterior and mediolateral tilt data suitable for high-content screening of compounds affecting vestibular or cerebellar function.
• Quantitative Output: Delivers continuous motion metrics that enable dose-response analysis and threshold-based feedback optimization.
• Scalability: Portable design allows deployment across multiple sites for cross-laboratory reproducibility in target validation campaigns.

Translational & Preclinical Research

• Disease Relevance: Models sitting-related balance deficits seen in Parkinson’s, MS, TBI, and muscular dystrophy, supporting preclinical continuity.
• Mechanistic De-risking: Isolates the contribution of vibrotactile feedback to motor learning, enabling prioritization of neuromodulation targets with higher predictive confidence.
• Translational Biomarker Alignment: Posturographic measures serve as functional biomarkers correlating with clinical balance scales, aiding go/no-go decisions.

Pipeline & Workflow Integration

The device fits within the discovery-to-preclinical continuum, supporting hypothesis testing in early discovery, assay standardization in screening, and functional validation in translational research.

• Discovery Biology: Facilitates pathway clarification by isolating the effects of sensory feedback on motor output during perturbed sitting.
• Screening: Enables assay readiness through standardized, quantifiable tilt measurements that detect subtle changes in postural stability.
• Analytics: Provides real-time motion data and derived metrics (e.g., frequency dispersion) for statistical comparison across experimental conditions.
• Translational Research: Bridges discovery and preclinical work by validating balance improvements in a disease-relevant, ecologically relevant sitting paradigm.
• Enterprise Reuse: Reusable platform design supports longitudinal studies and cross-functional teams in neuroscience and rehabilitation research.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in target validation by reducing ambiguity in sensorimotor mechanism interpretation.
• Operational Value: Ensures reproducibility through standardized feedback thresholds and motion tracking protocols.
• Strategic Value: Improves go/no-go decisions by providing objective, quantifiable balance outcomes prior to animal testing.
• Portfolio Impact: Enables risk-adjusted prioritization of neuromodulation or rehabilitative candidates based on functional sitting performance.

Implementation Considerations

• Requires expertise in biomechanics, neuroscience, or rehabilitation engineering for setup and data interpretation.
• Depends on inertial measurement units, microcontrollers, and vibratory actuators for closed-loop feedback functionality.
• Necessitates cross-team standardization of feedback thresholds and trial parameters for multi-site reproducibility.
• Adaptation across model systems may require scaling of platform dimensions and feedback intensity.
• Practical limitations include dependency on user compliance with posture instructions and environmental vibration interference.

Biopharma FAQs